Literature DB >> 9883794

Estimating prevalence of type 1 and type 2 diabetes in a population of African Americans with diabetes mellitus.

J P Boyle1, M M Engelgau, T J Thompson, M G Goldschmid, G L Beckles, D S Timberlake, W H Herman, D C Ziemer, D L Gallina.   

Abstract

The pathogenesis, treatment, and outcomes of type 1 and type 2 diabetes differ. Current surveys derive population-based estimates of diabetes prevalence by type using limited clinical information and applying classification rules developed in white populations. How well these rules perform when deriving similar estimates in African American populations is unknown. For this study, data were collected on a group of African Americans with diabetes who enrolled at the Diabetes Unit of Grady Memorial Hospital in Atlanta, Georgia, from April 16, 1991, to November 1, 1996. The data were used to develop some simple classification rules for African Americans based on a classification tree and a logistic regression model. Sensitivities and specificities, in which fasting C-peptide was used as the gold standard, were determined for these rules and for two current rules developed in mostly white, non-Hispanic populations. Rules that yielded precise (minimum variance unbiased) estimates of the prevalence of type 1 diabetes were preferred. The authors found that a rule based on the logistic regression model was best for estimating type 1 prevalences ranging from 1% to 17%. They concluded that simple classification rules can be used to estimate prevalence of diabetes by type in African American populations and that the optimal rule differs somewhat from the current rules.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9883794     DOI: 10.1093/oxfordjournals.aje.a009728

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  16 in total

Review 1.  Emerging Approaches in Surveillance of Type 1 Diabetes.

Authors:  Sharon Saydah; Giuseppina Imperatore
Journal:  Curr Diab Rep       Date:  2018-07-11       Impact factor: 4.810

2.  Socioeconomic status and type 2 diabetes in African American and non-Hispanic white women and men: evidence from the Third National Health and Nutrition Examination Survey.

Authors:  J M Robbins; V Vaccarino; H Zhang; S V Kasl
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

3.  Anti-Hyperglycemic Properties of Crude Extract and Triterpenes from Poria cocos.

Authors:  Tzu-Hsuan Li; Chia-Chung Hou; Cicero Lee-Tian Chang; Wen-Chin Yang
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-16       Impact factor: 2.629

Review 4.  Botanical, Pharmacological, Phytochemical, and Toxicological Aspects of the Antidiabetic Plant Bidens pilosa L.

Authors:  Wen-Chin Yang
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-29       Impact factor: 2.629

5.  Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus in Saudi Arabia: A Post Authorization Safety Study.

Authors:  Abdullah M Alguwaihes
Journal:  Diabetes Ther       Date:  2021-06-12       Impact factor: 2.945

6.  Antidiabetic effect and mode of action of cytopiloyne.

Authors:  Cicero Lee-Tian Chang; Hsien-Yueh Liu; Tien-Fen Kuo; Yi-Jou Hsu; Ming-Yi Shen; Chien-Yuan Pan; Wen-Chin Yang
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-13       Impact factor: 2.629

7.  Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compounds.

Authors:  Cicero L T Chang; Yenshou Lin; Arlene P Bartolome; Yi-Ching Chen; Shao-Chih Chiu; Wen-Chin Yang
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-04       Impact factor: 2.629

8.  Antidiabetic Activity of Polysaccharides from Tuberous Root of Liriope spicata var. prolifera in KKAy Mice.

Authors:  Yihui Liu; Luosheng Wan; Zuoqi Xiao; Jingjing Wang; Yonglong Wang; Jiachun Chen
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-26       Impact factor: 2.629

Review 9.  Can clinical features be used to differentiate type 1 from type 2 diabetes? A systematic review of the literature.

Authors:  Beverley M Shields; Jaime L Peters; Chris Cooper; Jenny Lowe; Bridget A Knight; Roy J Powell; Angus Jones; Christopher J Hyde; Andrew T Hattersley
Journal:  BMJ Open       Date:  2015-11-02       Impact factor: 2.692

10.  Insulin combined with Chinese medicine improves glycemic outcome through multiple pathways in patients with type 2 diabetes mellitus.

Authors:  Xinxia Zhang; Ya Liu; Daqian Xiong; Chunguang Xie
Journal:  J Diabetes Investig       Date:  2015-04-27       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.